FULCRUM THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
FULCRUM THERAPEUTICS, INC. (FULC) reported Increase (Decrease) in Other Operating Assets of -$529.00 thousand for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-09-02
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$537.00K, a 26950.00% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $8.00K.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $529.00K.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$3.00K.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2023 was -$94.00K, a 106.02% decline from fiscal 2022.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2022 was $1.56M.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2021 was -$36.00K, a 106.94% decline from fiscal 2020.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2020 was $519.00K, a 2495.00% increase from fiscal 2019.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$537.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | -$529.00K S-4 · filed 2026-09-02 | $0.00 derived: sum of 3 quarters · filed 2026-09-02 | -$3.00K derived: sum of 4 quarters · filed 2026-09-02 | |||
| 2026-03-31 | $8.00K 10-Q · filed 2026-04-27 | $537.00K derived: sum of 2 quarters · filed 2026-09-02 | $534.00K derived: sum of 3 quarters · filed 2026-09-02 | $536.00K derived: sum of 4 quarters · filed 2026-09-02 | |||
| 2025-12-31 | $529.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | $526.00K derived: sum of 2 quarters · filed 2026-09-02 | $528.00K derived: sum of 3 quarters · filed 2026-09-02 | $528.00K S-4 · filed 2026-09-02 | |||
| 2025-09-30 | -$3.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-10-29 | -$1.00K derived: sum of 2 quarters · filed 2026-09-02 | -$1.00K 10-Q · filed 2025-10-29 | -$67.00K derived: sum of 4 quarters · filed 2026-09-02 | |||
| 2025-06-30 | $2.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | $2.00K S-4 · filed 2026-09-02 | -$64.00K derived: sum of 3 quarters · filed 2026-09-02 | -$1.98M derived: sum of 4 quarters · filed 2026-09-02 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-27 | -$66.00K derived: sum of 2 quarters · filed 2026-09-02 | -$1.98M derived: sum of 3 quarters · filed 2026-09-02 | -$1.98M derived: sum of 4 quarters · filed 2026-09-02 | |||
| 2024-12-31 | -$66.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | -$1.98M derived: sum of 2 quarters · filed 2026-09-02 | -$1.98M derived: sum of 3 quarters · filed 2026-09-02 | -$2.00M S-4 · filed 2026-09-02 | |||
| 2024-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$1.91M derived: sum of 2 quarters · filed 2025-10-29 | -$1.94M 10-Q · filed 2025-10-29 | -$1.91M derived: sum of 4 quarters · filed 2025-10-29 | |||
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$22.00K 10-Q · filed 2025-07-29 | -$1.00K derived: sum of 3 quarters · filed 2025-07-29 | -$6.00K derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2024-03-31 | -$23.00K 10-Q · filed 2025-05-01 | -$2.00K derived: sum of 2 quarters · filed 2025-05-01 | -$7.00K derived: sum of 3 quarters · filed 2025-05-01 | -$43.00K derived: sum of 4 quarters · filed 2025-05-01 | |||
| 2023-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $16.00K derived: sum of 2 quarters · filed 2025-02-25 | -$20.00K derived: sum of 3 quarters · filed 2025-02-25 | -$94.00K 10-K · filed 2025-02-25 | |||
| 2023-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$41.00K derived: sum of 2 quarters · filed 2024-11-13 | -$115.00K 10-Q · filed 2024-11-13 | $3.00M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$110.00K 10-Q · filed 2024-07-31 | $3.01M derived: sum of 3 quarters · filed 2024-07-31 | $3.02M derived: sum of 4 quarters · filed 2024-07-31 | |||
| 2023-03-31 | -$74.00K 10-Q · filed 2024-05-13 | $74.00K 10-Q · filed 2023-05-15 | $3.04M derived: sum of 2 quarters · filed 2024-05-13 | $3.05M derived: sum of 3 quarters · filed 2024-05-13 | $1.76M derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.13M derived: sum of 2 quarters · filed 2024-02-27 | $1.84M derived: sum of 3 quarters · filed 2024-02-27 | $1.56M 10-K · filed 2024-02-27 | |||
| 2022-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.28M derived: sum of 2 quarters · filed 2023-11-07 | -$1.56M 10-Q · filed 2023-11-07 | $1.56M 10-Q · filed 2022-11-08 | -$1.53M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.56M 10-Q · filed 2023-08-03 | $1.56M 10-Q · filed 2022-08-11 | -$1.54M derived: sum of 3 quarters · filed 2023-08-03 | -$1.55M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | -$274.00K 10-Q · filed 2023-05-15 | $274.00K 10-Q · filed 2022-05-09 | -$251.00K derived: sum of 2 quarters · filed 2023-06-26 | -$263.00K derived: sum of 3 quarters · filed 2023-06-26 | -$295.00K derived: sum of 4 quarters · filed 2023-06-26 | ||
| 2021-12-31 | $23.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $11.00K derived: sum of 2 quarters · filed 2023-06-26 | -$21.00K derived: sum of 3 quarters · filed 2023-06-26 | -$36.00K 10-K/A · filed 2023-06-26 | |||
| 2021-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$44.00K derived: sum of 2 quarters · filed 2022-11-08 | -$59.00K 10-Q · filed 2022-11-08 | -$97.00K derived: sum of 4 quarters · filed 2023-06-26 | |||
| 2021-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$47.00K 10-Q · filed 2022-08-11 | -$85.00K derived: sum of 3 quarters · filed 2023-06-26 | $455.00K derived: sum of 4 quarters · filed 2023-06-26 | |||
| 2021-03-31 | -$15.00K 10-Q · filed 2022-05-09 | -$53.00K derived: sum of 2 quarters · filed 2023-06-26 | $487.00K derived: sum of 3 quarters · filed 2023-06-26 | $484.00K derived: sum of 4 quarters · filed 2023-06-26 | |||
| 2020-12-31 | -$38.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $502.00K derived: sum of 2 quarters · filed 2023-06-26 | $499.00K derived: sum of 3 quarters · filed 2023-06-26 | $519.00K 10-K/A · filed 2023-06-26 | |||
| 2020-09-30 | $540.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $537.00K derived: sum of 2 quarters · filed 2021-11-04 | $557.00K 10-Q · filed 2021-11-04 | $557.00K derived: sum of 4 quarters · filed 2023-06-23 | |||
| 2020-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $17.00K 10-Q · filed 2021-08-10 | $17.00K derived: sum of 3 quarters · filed 2023-06-23 | -$549.00K derived: sum of 4 quarters · filed 2023-06-23 | |||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-06 | $20.00K derived: sum of 2 quarters · filed 2023-06-23 | -$546.00K derived: sum of 3 quarters · filed 2023-06-23 | -$23.00K derived: sum of 4 quarters · filed 2023-06-23 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-23 | -$566.00K derived: sum of 2 quarters · filed 2023-06-23 | -$43.00K derived: sum of 3 quarters · filed 2023-06-23 | $20.00K 10-K/A · filed 2023-06-23 | |||
| 2019-09-30 | -$566.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$43.00K derived: sum of 2 quarters · filed 2020-11-10 | $20.00K 10-Q · filed 2020-11-10 | $18.00K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $586.00K 10-Q · filed 2020-08-11 | $584.00K derived: sum of 3 quarters · filed 2020-08-11 | $602.00K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | $63.00K 10-Q · filed 2020-05-13 | $61.00K derived: sum of 2 quarters · filed 2020-05-13 | $79.00K derived: sum of 3 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $16.00K derived: sum of 2 quarters · filed 2020-03-05 | -$22.00K 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$20.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | -$38.00K 10-Q · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |